| |
著者: Bhumsuk Keam, Chang Kyung Kang, Kang Il Jun, Song Mi Moon, Koung Jin Suh, Dae-Won Lee, Chan-Young Ock, Miso Kim, Yunhee Choi, Yoojoo Lim, Kyung-Hun Lee, Se Hyun Kim, Tae Min Kim, Tae-Yong Kim, Do-Youn Oh, Dong-Wan Kim, Seock-Ah Im, Jong Seok Lee, Eu Suk Kim, Hong Bin Kim, Nam-Joong Kim, Yu Jung Kim, Wan Beom Park, Myoung-Don Oh
雑誌名: Clin Infect Dis. 2020 Jul 11;71(2):422-425. doi: 10.1093/cid/ciz1092.
Abstract/Text
Among prospectively enrolled adult patients with cancer receiving immune checkpoint inhibitors (ICIs; n = 46) or cytotoxic agents (n = 90), seroprotection and seroconversion rates after seasonal quadrivalent influenza vaccinations were higher with ICI than with cytotoxic chemotherapy. These results support annual influenza vaccinations for cancer patients receiving ICIs. Clinical Trials Registration clinicaltrials.gov (NCT03590808).
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
PMID 31680143 Clin Infect Dis. 2020 Jul 11;71(2):422-425. doi: 10.1093/cid/ciz1092.
|
